ENPP1 and breast carcinoma: Additionally, many studies indicate that ENPP1 is highly expressed in many cancers, including lung cancer (16), ovarian cancer (17) and breast cancer (18), and that this overexpression is a strong indicator of poor prognosis in different cancers.